evaluation
long
term
tobramycin
therapy
patients
cystic
fibrosis
advanced
pulmonary
disease
nine
cystic
fibrosis
patients
chronic
bronchopulmonary
infection
severely
damaged
lungs
invaded
pseudomonas
aeruginosa
eleven
courses
prolonged
tobramycin
treatment
mg
kg
day
four
weeks
administered
pulmonary
symptoms
improved
better
quality
life
achieved
one
patient
objective
parameters
chest
x
ray
pulmonary
function
tests
changed
lesser
extent
one
patient
pseudomonas
eradicated
sputum
reappeared
discontinuation
therapy
rest
patients
pseudomonas
significantly
suppressed
replaced
pathogens
four
patients
showed
rises
antibody
titres
candida
two
aspergillus
fumigatus
nephrotoxic
side
effects
observed
vestibular
function
reversibly
impaired
one
patient
without
corresponding
clinical
symptoms
bacterial
resistance
tobramycin
observed
therapy
